View the NewsRx Library

Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Google 2009 PageRank: #2 Among Top Health News and Media Publications

Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology

Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals

Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This site complies with the HONcode standard for trustworthy health information:
verify here.

Clinical Trials Week

Susan Hasty, Publisher
Table of Contents . . . August 24th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

American Association for Cancer Research - Budesonide is not beneficial for the treatment of diarrhea in metastatic melanoma patients

BioTime, Inc. - BioTime Appoints Walter Funk Vice President for Stem Cell Research

Depomed, Inc. - Depomed Reports Encouraging Results of its Phase I Trial for DM-1992 Program in Parkinson's Disease

Gene Signal - Gene Signal Announces Publication of Phase I Data Highlighting Safety of GS-101 for Diseases of the Eye

Osteoporosis - Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss

Anti-Infectives - Research results from D. Krievins and co-authors update knowledge of anti-infectives

Cancer - Studies conducted at University of Wisconsin on cancer recently published

Cancer Vaccines - Data on cancer vaccines detailed by researchers at University of Maryland

Cardiac Surgery - New cardiac surgery study results reported from Southampton University

Hepatitis C Virus - Data on hepatitis C virus published by S.L. Bogen and colleagues

Hypopharyngeal Cancer - Study data from University of Leipzig provide new insights into hypopharyngeal cancer

Immunization - New immunization research from Charite University discussed

Lymphoma - Research on lymphoma published by scientists at Lille University

Non-Small Cell Lung Cancer - Northwestern University publishes research in non-small cell lung cancer

Non-Small Cell Lung Cancer - Researchers at Karolinska University have published new data on non-small cell lung cancer

Pharmacokinetics - Data on pharmacokinetics published by E.S.D. Ashley and colleagues

Polycythemia Vera - Reports on polycythemia vera findings from University of Texas provide new insights

Prostate Cancer - Data on prostate cancer reported by G.P. Stathopoulos and co-researchers

Prostate Cancer - Reports summarize prostate cancer study results from K. Fizazi and co-researchers

T-Cell Leukemia - American University of Beirut reports research in t-cell leukemia

Vascular Endothelial Growth Factor - Studies from Massachusetts General Hospital describe new findings in vascular endothelial growth factor

Gastroenterology - Data from NHS Foundation Trust, Department of Medical Oncology advance knowledge in gastroenterology

Gene Therapy - Studies from Harvard University add new findings in the area of gene therapy

Glioblastoma Therapy - Studies from University of Texas, M.D. Anderson Cancer Center yield new information about glioblastoma therapy

Prostate Cancer Therapy - Study findings from University Medical Center, Department of Nuclear Medicine provide new insights into prostate cancer therapy

Advanced Cell Technology, Inc. - Edmund Mickunas Named Vice President of Regulatory for Advanced Cell Technologies

Adverse Drug Reactions - Omeros Announces Positive Clinical Results of Phase 1/Phase 2 Trial of OMS302 for Use During Ophthalmologic Surgery

Alder Biopharmaceuticals, Inc. - Alder Biopharmaceuticals Appoints Dr. Mark D. Young Senior VP Pharmaceutical Operations

Alzheimer Disease - Accera Announces Peer-Reviewed Publication of the Results of its 90-Day Clinical Study of AC-1202 (Axona(TM) ) in Mild to Moderate Alzheimer's Disease

Antares Pharma, Inc. - Antares Pharma Reports Second Quarter 2009 Financial and Operating Results

Array BioPharma Inc. - Array BioPharma Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2009

Array BioPharma Inc. - Array BioPharma Reports Positive Results of Its Oral Glucokinase Activator in Type 2 Diabetes Patients

ARYx Therapeutics, Inc. - ARYx Therapeutics Reports Second Quarter 2009 Results

Atrial Fibrillation - Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement

Bioengineering - Oxygen Biotherapeutics, Inc. to Begin Oxycyte(R) Phase II Clinical Trials in Switzerland

Bionovo, Inc. - Bionovo Announces Second Quarter 2009 Highlights and Financial Results

Biopharmaceuticals - Cempra Pharmaceuticals Announces Appointment of John H. Johnson to Board of Directors

Biotechnology Business - MedImmune Advances Three Oncology Programs Into the Clinic

Bladder Cancer - OncoGenex Expands Clinical Development of OGX-427 with a Phase 1 Clinical Trial in Bladder Cancer

Cancer - terna Zentaris Reports Second Quarter 2009 Financial and Operating Results

Clinical Data, Inc. - Clinical Data, Inc. Reports First Quarter Fiscal 2009 Results

Clinical Trial Research - Pharmos Corporation Reports 2009 Second Quarter Results

Cortex Pharmaceuticals, Inc. - Cortex Reports Second Quarter Operating Results

Endocyte Inc. - Endocyte Announces Positive Results from a Phase II Clinical Study of EC145 in Patients with Advanced Non-Small Cell Lung Cancer NSCLC

Genta Incorporated - Genta Incorporated Announces Second Quarter 2009 Financial Results

Hepatitis C Virus - ANA773 Demonstrates Significant Antiviral Response in Early Clinical Trial in Hepatitis C Patients

Hepatitis C Virus - Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial

HIV/AIDS - GeoVax Labs, Inc. Announces Six Month 2009 Financial Results and Provides Operational Update

Inhibitex, Inc. - Inhibitex Reports Second Quarter 2009 Financial Results

Knopp Neurosciences Inc. - Knopp Neurosciences to Present Phase 2 Results of KNS-760704 in ALS

Opexa Therapeutics, Inc. - Opexa Regains NASDAQ Compliance Following Stem Cell Agreement

Palatin Technologies, Inc. - Palatin Technologies, Inc. Reports Positive Bremelanotide Study; Improved Safety Profile with Subcutaneous Administration

Pluristem Therapeutics Inc. - Pluristem Therapeutics Will Present the Phase I Study for PLX-PAD in Critical Limb Ischemia at MSC2009 Regenerative Medicine and Adult Stem Cell Therapy Conference

Regeneron Pharmaceuticals, Inc. - Regeneron Announces Presentation at the 29th Annual Canaccord Adams Global Growth Conference

Research and Markets - 2009 Report Collagens Clinical Trial Analysis Covers Information on Each Product Being Clinically Tested With Detailed Coverage

Salix Pharmaceuticals - Salix Pharmaceuticals Reports 2Q2009 Results Updates Full Year Guidance

Smallpox - Chimerix Raises $16.1 Million in Series E Financing

Type 1 Diabetes - Tolerx Announces Amendment to Phase 3 DEFEND Protocol

Return to Top of Page


Home \| Free Newsletters \| Products \| Article Library \| About Us \| Contact \| Privacy Policy \| Search \| Visit VerticalNews.com Copyright © 2009 NewsRx